GW
Pharmaceuticals
are not involved in outdoor planting (outdoor plantations would
involve industrial hemp which has been grown under licence in
recent years), and receive advice from some of the top world experts
on cannabis cultivation. They are breeding plants to be able to
produce a reliable cannabinoid profile (i.e. not just THC) in
order to test different balances for treating conditions such
as pain and MS. The intention is to reduce raw plant material
down to the equivalent of "grass oil", and dilute this
with a carrier liquid for use in inhalers etc. The cannabinoid
balance is important, as cannabidiol (CBD) shows as much promise
as THC therapeutically, whereas THC appears to be a painkiller,
CBD appears to be an anticonvulsant with a different method of
action, and recent studies have shown it to be neuroprotective
against brain damage following strokes (and possibly, in theory,
against neurodegeneration caused by ecstasy). CBD is normally
found in hashish, with little present in bush or skunk, and can
take the edge off a THC high, and can make users less anxious
and paranoid. For more info click here
|
All contents of this web site & any links to other sites etc, is for educational & research purposes. IDMU at no time seeks to encourage illegal activities. All sections of this site and its contents are protected under copyright laws. © IDMU Ltd 1994 - 2007. Website design by Freelance Graphics |